Cargando…
Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial
BACKGROUND: Nitroglycerin is proposed as an agent to reduce tumour hypoxia by improving tumour perfusion. We investigated the potential of nitroglycerin as a radio-sensitizer in non-small cell lung cancer (NSCLC) and the potential of functional imaging for patient selection. MATERIAL AND METHODS: Tr...
Autores principales: | Reymen, Bart J.T., van Gisbergen, Marike W., Even, Aniek J.G., Zegers, Catharina M.L., Das, Marco, Vegt, Erik, Wildberger, Joachim E., Mottaghy, Felix M., Yaromina, Ala, Dubois, Ludwig J., van Elmpt, Wouter, De Ruysscher, Dirk, Lambin, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993056/ https://www.ncbi.nlm.nih.gov/pubmed/32021913 http://dx.doi.org/10.1016/j.ctro.2019.12.002 |
Ejemplares similares
-
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion
por: van Elmpt, Wouter, et al.
Publicado: (2015) -
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
por: Even, Aniek J.G., et al.
Publicado: (2016) -
Tumor regression during radiotherapy for non-small cell lung cancer patients using cone-beam computed tomography images
por: van Timmeren, J. E., et al.
Publicado: (2019) -
The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses
por: Rekers, Nicolle H., et al.
Publicado: (2018) -
Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
por: van Kuijk, Simon J. A., et al.
Publicado: (2016)